FIELD: pharmacology. SUBSTANCE: the present innovation deals with aerosol preparations to be applied for inhalation therapy and containing medicinal preparation as beta-agonist either in suspension or in solution at normed supply in sealed inhalator. The present innovation provides stability under conditions of approximately 90 C and about 75% specific moisture for, at least, about 4- wk-long period. EFFECT: higher efficiency. 34 cl, 2 dwg, 20 ex, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| TROVENTOL-BASED COMPOSITION | 2006 |
|
RU2457832C2 |
| PHARMACEUTICAL AEROSOL COMPOSITION | 2009 |
|
RU2565438C2 |
| PHARMACEUTICAL AEROSOL FORMULATIONS OF FORMOTEROL AND BECLOMETASONE DIPROPIONATE | 2010 |
|
RU2650175C2 |
| COMPOSITIONS, METHODS AND SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS | 2010 |
|
RU2586297C2 |
| COMBINATION TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2010 |
|
RU2561052C2 |
| APPLICATION OF TIOTROPIUM SALTS FOR TREATMENT OF SEVERE FORMS OF PERSISTENT ASTHMA | 2006 |
|
RU2422144C2 |
| CRYSTALLINE LEVOSALBUTAMOL SULFATE, METHOD OF ITS OBTAINING AND PHARMACEUTICAL COMPOSITION, WHICH CONTAINS IT | 2005 |
|
RU2440972C2 |
| CRYSTALLINE MICRO PARTICLES OF BETA-AGONIST, COATED WITH FATTY ACID | 2012 |
|
RU2629085C2 |
| COMPOSITIONS FOR PULMONARY DELIVERY OF LONG-ACTING MUSCARINIC RECEPTOR ANTAGONISTS AND LONG-ACTING B2-ADRENERGIC RECEPTOR AGONISTS AND METHODS AND SYSTEMS ASSOCIATED THEREWITH | 2010 |
|
RU2713404C2 |
| COMPOSITIONS FOR PULMONARY DELIVERY OF LONG-ACTING MUSCARINIC ANTAGONISTS AND LONG-ACTING β-ADRENERGIC RECEPTOR AGONISTS AND RELATED METHODS AND SYSTEMS | 2010 |
|
RU2574893C2 |
